Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy, TKI, and Anti-PD-1 in Advanced Colorectal Cancer
NCT07467590Phase 2Not yet recruiting
- Start
- Apr 2026
- Primary completion
- Apr 2028
01
Overview
Phase 2, open-label, single-arm trial in colorectal cancer (CRC). Primary endpoint: Objective Response Rate. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07467590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467590.